Capital Analysts LLC’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1K Hold
152
﹤0.01% 1527
2026
Q1
$1K Hold
152
﹤0.01% 1527
2025
Q4
$1K Hold
152
﹤0.01% 1462
2025
Q3
$1K Hold
152
﹤0.01% 1421
2025
Q2
$1K Hold
152
﹤0.01% 1375
2025
Q1
$1K Buy
152
+68
+81% +$688 ﹤0.01% 1354
2024
Q4
$1K Hold
84
﹤0.01% 1282
2024
Q3
$1K Hold
84
﹤0.01% 1298
2024
Q2
$1K Hold
84
﹤0.01% 1189
2024
Q1
$1K Sell
84
-56
-40% -$1.02K ﹤0.01% 1101
2023
Q4
$3K Buy
140
+56
+67% +$1.03K ﹤0.01% 1002
2023
Q3
$2K Hold
84
﹤0.01% 1063
2023
Q2
$2K Hold
84
﹤0.01% 959
2023
Q1
$2K Hold
84
﹤0.01% 928
2022
Q4
$2K Hold
84
﹤0.01% 1005
2022
Q3
$2K Sell
84
-28
-25% -$982 ﹤0.01% 1018
2022
Q2
$4K Hold
112
﹤0.01% 897
2022
Q1
$8K Sell
112
-68
-38% -$4.9K ﹤0.01% 781
2021
Q4
$17K Buy
180
+68
+61% +$8.13K ﹤0.01% 746
2021
Q3
$14K Hold
112
﹤0.01% 751
2021
Q2
$19K Hold
112
﹤0.01% 678
2021
Q1
$20K Sell
112
-112
-50% -$26K ﹤0.01% 719
2020
Q4
$45K Buy
224
+8
+4% +$1.63K ﹤0.01% 433
2020
Q3
$47K Buy
216
+146
+209% +$30.9K ﹤0.01% 413
2020
Q2
$13K Buy
70
+30
+75% +$5.26K ﹤0.01% 523
2020
Q1
$6K Buy
+40
New +$4.65K ﹤0.01% 572

Other funds holding TDOC

Capital Analysts LLC's TDOC Position: Q2 2026 in Review

Capital Analysts LLC held its Teladoc Health (TDOC) position steady in Q2 2026 at 152 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Capital Analysts LLC first reported a position in TDOC in Q1 2020 and has held it in 26 quarters since. The position peaked at $47K in Q3 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Capital Analysts LLC held 152 shares of Teladoc Health worth $1K as of Q2 2026.
  • Capital Analysts LLC left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1527 holding.
  • Capital Analysts LLC first reported a position in Teladoc Health in Q1 2020 and has held it in 26 quarters since.
  • Capital Analysts LLC's Teladoc Health position peaked at $47K in Q3 2020.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.